RxDoctor Payments Data

Peter Lallas

Podiatrist · Kirkland, WANPI 1972556918

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,338 of the $2,913 with a category attached, or 80.2%. Paragon 28, Inc. accounts for 89.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $2,599 and has fallen 98.6% since, to $35 in 2025.

$2,913in general payments, 2019–2025

Across 19 payments — averaging $153.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$3K
  • Stryker$108
  • Zimmer Biomet$60
  • Bioventus LLC$38
  • Orthofix Medical, Inc.$38
  • Pacira Pharmaceuticals Incorporated$35
  • plus $24 from 1 others

What the payments were for

  • Consulting fees$2,33880%
  • Travel & lodging$1726%
  • Food & beverage$40314%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,913 in reported general payments places this provider in the 75th percentile of 134 podiatrist providers in Washington.

See all podiatrist providers in Washington

Medicare billing

Part B allowed, 2024
$56,473
Medicare patients
251
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl15$188
Oxycodone Hcl26$77

Paid to pharmacies, not to this prescriber.

Other podiatrist in Kirkland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →